With the credit facility, SBi will fully repay $13 million of its existing debt and will build upon its core business by funding the introduction in 2010 of several new products and improved versions of existing products for both the upper and lower limb anatomies, according to the release.
SBi also plans to build-out instrument sets to further support its product portfolio and to focus on evidence-based medicine, by developing and initiating several studies to better support clinical understanding of its product portfolio, according to the release.
Read the release about Small Bone Innovations.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
